A Bioelectronic Medicine Company

advancing the treatment of autoimmune diseases.

About Us

Boomerang Medical is a women-led bioelectronic medicine company on a mission to disrupt the treatment of autoimmune diseases. The company is developing a bioelectric neuromodulation technology, which has been granted Breakthrough Device Designation by the FDA for the treatment of Crohn's disease and ulcerative colitis. The technology is currently being evaluated in an FDA-approved clinical trial at leading IBD centers in the US.

Our Focus

Inflammatory Bowel Disease (IBD) is one of the most debilitating autoimmune diseases, affecting millions globally. Living with Crohn's disease or ulcerative colitis impacts not just physical health, but also work, relationships, and well-being. Current treatments include medications and surgery, but the complexity of the condition means that there is always room for innovative approaches.

What if the next big leap in managing IBD is already hardwired into our bodies? That's the question propelling our focus on neuromodulation, a promising frontier in bioelectronic medicine.

Boomerang Medical is dedicated to promoting IBD awareness and education. We are proud to be a member of the Crohn’s & Colitis Foundation's Corporate Circle.

Boomerang Medical is headquartered in the heart of Silicon Valley on the campus of El Camino Hospital in Mountain View, California. We are proud to be a Company–In-Residence at the prestigious Fogarty Innovation incubator–the only healthcare-focused incubator of its kind in the US–giving us access to the brightest minds and expertise in the medical technology industry.

Does Inflammatory Bowel Disease disrupt your daily life?

Researchers in the BOOM-IBD Clinical Trial are exploring whether nerve stimulation, a therapy already approved by the FDA to treat other conditions, can be effective for treating Inflammatory Bowel Disease.

Join the trial

Meet the Team

Simonsen

President & Chief Executive Officer

Heather Simonsen

For 30 years, Heather has pursued her passion for solving the puzzle of bringing new medical technologies from bench to bedside. She is the former President of PQ Bypass, which was acquired in 2021 in one of the highest value vascular device transactions in recent history.

Chief Operating Officer

Pharoah Garma, MEng

Pharoah is a former FDA Senior Lead Reviewer and operational leader with a 20-year track record of leading high-performing teams to execute speed-to-patient strategies. She is a recognized expert in Class III medical devices and device/drug combination products.

Co-Founder, Chief Innovation + Technology Officer

David Miller, MEng

David is an innovator and entrepreneur, holding more than 50 patents spanning diverse technologies and clinical applications. With over 20 years of experience, David has co-founded multiple companies, is a Stanford BioDesign Fellow, and was previously a Distinguished Scientist and Technical Fellow at Medtronic.

Vice President, Clinical Affairs

Colleen Holthe

Colleen has a deep understanding of clinical research and regulatory affairs within the medical device industry. She holds 20+ years of experience conducting 25 clinical trials and a proven track record of leading Class III medical device trials from inception to FDA approval.

Vice President, Therapy Development

Lucas Payne

Lucas has 20+ years of experience leveraging his passion for patient care, HCP training and entrepreneurship to advance Class III medical device innovation for companies such as Johnson & Johnson and Abbott. Lucas began his career in the medical field in patient care as a radiation technologist.

Senior Director, Clinical + Field Operations

Malea D'Amico, CCRA, CCRP

Malea has spent 21 years on the front lines of clinical research in over 70 medtech and biotech clinical trials. An expert in clinical study quality assurance, her experience crosses all phases clinical trials including benchwork, QA, monitoring, field support and patient outreach.

Director of Finance

Mariela Baughman

Mariela is a finance and accounting expert with over 30 years of experience working for startup medical technology companies. Previously, she was the Director of Finance and Human Resources at PQ Bypass.

Project Manager, Clinical + Regulatory Affairs

Grace Booth

Grace is a Regulatory expert with 22 years of experience in implantable medical devices. From Design Dossiers and Technical Files to breakthrough devices, her experience with FDA, notified bodies, and international agencies covers the full product lifecycle.

Coordinator, Marketing + Clinical Research

Braden Koch

Braden is a strategic communicator who enjoys creating actionable marketing and communications solutions to produce measurable results for early-stage companies. Previously, Braden was on the portfolio services team at Norwest Venture Partners, providing marketing and networking support to 175+ companies.

Board of Directors + Advisors

Boomerang Medical is proud to be a portfolio company of

Arboretum Ventures and Hatteras Venture Partners, as well as a

Company-In-Residence at Fogarty Innovation.

Heather Simonsen

Boomerang Medical

President & CEO

Andrew Cleeland

Fogarty Innovation

Chief Executive Officer

Tom Shehab, MD

Arboretum Ventures

Managing Partner

Gayle Kuokka

Fogarty Innovation

Chief Financial Officer

Jeff Terrell

Hatteras Venture Partners

General Partner

Screen Shot 2022-10-10 at 11_edited_edit

John Morriss

Fogarty Innovation

Director of Innovation Acceleration

Scientific Advisors

Peter Irving, MA, MD, FRCP

Guy’s and St Thomas’ NHS Foundation Trust

Consultant Gastroenterologist

Kings College London

Professor of Inflammatory Bowel Disease

Edward Barnes, MD, MPH

University of North Carolina at Chapel Hill

Assistant Professor of Medicine,

Associate Fellowship Program Director

Gil Melmed, MD

Cedars-Sinai

Director of Inflammatory Bowel Disease Clinical Research Medicine

Kevin Benson, MD

Sanford Health

Urogynecologist, Obstetrician

Warren Grill, PhD

Duke University

Edmund T. Pratt, Jr. School Distinguished Professor of Biomedical Engineering

Laura Raffals, MD

Mayo Clinic

Professor of Medicine, Department of Medicine Associate Chair of Faculty Development, Vice Chair of the Division of Gastroenterology & Hepatology

Corey A. Siegel, MD, MS

Dartmouth-Hitchcock Medical Center

Section Chief of Gastroenterology and Hepatology, Co-Director of the IBD Center

Christian Stone, MD, MPH

Comprehensive Digestive Institute of Nevada

Gastroenterologist, Inflammatory Bowel Disease Specialist

Savitha Krishnan, MD

El Camino Health

Urogynecologist, Obstetrician

Sophie Payne, PhD

Bionics Institute

Senior Research Fellow, Head of the Peripheral Interface Neuromodulation Team

Boomerang Medical in the News

Anchor 1

Fogarty Companies Look to Continued Momentum in 2023

Fogarty Innovation | Nov 22, 2022

At Fogarty Innovation we are fortunate to have a front-row seat as our companies pioneer innovations that solve meaningful problems in patient care.

Here are six women-led life science startups to watch

San Francisco Business Times | Mar 3, 2023

We talked to the CEOs of some of the Bay Area's most promising life science startups to find

Boomerang Medical announces enrollment of first patients in IBD trial

Medical Device Network | Apr 18, 2023

The trial will assess the use of nerve stimulation as a potential treatment for Crohn’s disease and ulcerative colitis.

2495 Hospital Drive, Suite 300

Mountain View, CA 94040

(844) 423-9747

info@boomerangmedical.com